Found on pharmacist.com
Group by:
Title Date Type
Rite Aid will sell CBD products in 2 states, stop selling e-cigarettes in all stores
CNBC.com (04/11/19) LaVito, Angelica
Rite Aid reports it will start selling CBD creams, lotions, and lip balms in Washington and Oregon this month, testing public demand for cannabis-based consumer products. Walgreens and CVS also recently introduced similar products in some of their stores. Community pharmacies are evaluating the…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
FDA orders important safety labeling changes for flibanserin
FDA News Release (04/11/19)
Following a review of postmarketing studies, FDA has ordered a safety labeling change order for flibanserin (Addyi—Sprout Pharmaceuticals). The order requires Sprout to revise key safety information that women and their health care professionals should have when considering use of the drug.…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
Herbal drug kratom linked to almost 100 overdose deaths, CDC says
USA Today (04/11/19) Miller, Ryan W.
A new CDC report indicates that kratom, a plant grown in Southeast Asia and often sold OTC in powder capsules, has been connected with more deaths in recent years. According to CDC, kratom was a cause of death in 91 overdoses in the United States from July 2016 to December 2017. In seven cases,…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
Randomized trial of verubecestat for prodromal Alzheimer disease
New England Journal of Medicine (04/11/19) Vol. 380, No. 15, P. 1408 Egan, Michael F.; Kost, James; Voss, Tiffini; et al.
Researchers compared outcomes with verubecestat and with placebo in patients with prodromal Alzheimer disease. This population, who present with impaired memory and elevated brain amyloid levels but do not satisfy the clinical parameters for a dementia diagnosis, is ideal for evaluating drugs that…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
Incidence of type 2 diabetes in men receiving steroid 5alpha-reductase inhibitors
BMJ (04/10/19) Vol. 365 Wei, Li; Lai, Edward Chia-Cheng; Kao-Yang, Yea-Huei; et al.
With new evidence suggesting that steroid 5alpha-reductase inhibitors elevate the risk for type 2 diabetes, researchers in Taiwan and the United Kingdom scoured national health records for more proof. Specifically, they studied outcomes in men who took steroid dutasteride or finasteride to treat…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
Rite Aid reports mixed results for Q4
Chain Drug Review (04/11/19)
Rite Aid on Thursday reported net loss from continuing operations for the fourth quarter of $255.6 million, or 24 cents per share, adjusted net loss from continuing operations of $13.3 million, or 1 cent per share, results that fell below Wall Street’s expectations. "In the fourth quarter, we…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
Opioid sales reps swarmed New York at height of crisis
New York Times (04/12/19) Rashbaum, William; Rabin, Roni Caryn; Hakim, Danny
Purdue Pharma's sales force swept through New York State, visiting doctors, and pharmacies nearly half a million times between 2006 and 2017 to promote oxycodone (OxyContin) and other opioid analgesics. The company's sales strategy was among the new disclosures contained in court papers filed on…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
Walgreens, VillageMD partner on Houston primary care clinics
Drug Store News (04/10/19) Salazar, David
In a new partnership, Walgreens and primary care provider VillageMD will work to improve access to primary care in Houston. VillageMD will operate primary care clinics, called Village Medical at Walgreens, next to five Walgreens locations in Houston. The first such location is set to open by year-…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
Hawaii primary care network opens in-house pharmacy
Becker's Hospital Review (04/08/19) Paavola, Alia
The Bay Clinic, which has eight locations on the Big Island in Hawaii, has unveiled a new in-house pharmacy at its Keaau Family Health and Dental Center. The pharmacy is operated under the 340B drug discount program, which requires drug companies to offer medications at discounted prices through…
Apr 11, 2019 Publication Pharmacy Today Daily Edition
FDA issues final rule on safety and effectiveness of consumer hand sanitizers
FDA News Release (04/11/19)
FDA issued on Thursday a final rule that prohibits the use of certain active ingredients in OTC hand sanitizers. Additionally, the rule aims to ensure that FDA's safety and effectiveness evaluations and determinations for consumer antiseptic rub active ingredients are consistent, up-to-date, and…
Apr 11, 2019 Publication Pharmacy Today Daily Edition